Hims & Hers Health, Inc. (HIMS)
22.28
-2.76
(-11.04%)
USD |
NYSE |
May 18, 16:00
22.38
+0.10
(+0.43%)
After-Hours: 19:35
Hims & Hers Health Research and Development Expense (Quarterly) : 46.94M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.51B |
| Tango Therapeutics, Inc. | 33.07M |
| Johnson & Johnson | 3.495B |
| OPKO Health, Inc. | 29.20M |
| Abbott Laboratories | 767.00M |